Matthew Judson is a research associate in the UNC Neuroscience Center at the University of North Carolina at Chapel Hill.
Matthew Judson
Research associate
University of North Carolina at Chapel Hill
From this contributor
Angelman syndrome: Bellwether for genetic therapy in autism
It is not a matter of whether there will be clinical trials of genetic therapy for Angelman syndrome, but when.
Angelman syndrome: Bellwether for genetic therapy in autism
By
Matthew Judson, Benjamin Philpot
16 October 2018 | 6 min read
Insights for autism from Angelman syndrome
Deletions or duplications of the UBE3A gene lead to both Angelman syndrome and some cases of autism, respectively. Studying the effects of altered gene dosage in this region will provide insights into brain defects and suggest targets for therapies for both disorders, says expert Benjamin Philpot.
Insights for autism from Angelman syndrome
By
Benjamin Philpot, Angela Mabb, Matthew Judson
19 July 2011 | 6 min read
Explore more from The Transmitter
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.
Cell atlas cracks open ‘black box’ of mammalian spinal cord development
The atlas details the genetics, birth dates and gene-expression signatures of roughly 150 neuron subtypes in the dorsal horn of the mouse spinal cord.
By
Natalia Mesa
3 February 2026 | 5 min read
Pangenomic approaches to the genetics of autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 February.
Pangenomic approaches to the genetics of autism, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 2 February.
By
Jill Adams
3 February 2026 | 2 min read
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
Betting blind on AI and the scientific mind
If the struggle to articulate an idea is part of how you come to understand it, then tools that bypass that struggle might degrade your capacity for the kind of thinking that matters most for actual discovery.
By
Tim Requarth
2 February 2026 | 11 min read